MIST Stock Summary and Trading Ideas (Milestone Pharmaceuticals - Common Shares | NASDAQ:MIST)

Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.

Milestone Pharmaceuticals - Common Shares trades on the NASDAQ stock market under the symbol MIST.

As of August 13, 2026, MIST stock price declined to $1.11 with 887,818 million shares trading.

MIST has a beta of 3.57, meaning it tends to be more sensitive to market movements. MIST has a correlation of 0.29 to the broad based SPY ETF.

MIST has a market cap of $138.19 million. This is considered a Micro Cap stock.

Last quarter Milestone Pharmaceuticals - Common Shares reported $559,000 in Revenue and -$.21 earnings per share. This fell short of revenue expectation by $-254,336 and missed earnings estimates by -$.02.

In the last 3 years, MIST traded as high as $3.52 and as low as $.63.

The top ETF exchange traded funds that MIST belongs to (by Net Assets): GWX.

MIST has underperformed the market in the last year with a price return of -33.1% while the SPY ETF gained +22.4%. MIST has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -41.6% and +6.7%, respectively, while the SPY returned +5.8% and +6.8%, respectively.

MIST support price is $1.08 and resistance is $1.17 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MIST shares will trade within this expected range on the day.